Dr. Matthew Troung

Dr. Matthew Troung
Dr. Truong is board certified by the American Board of Urology. He is a general urologist and urologic oncologist (Society of Urologic Oncology fellowship at the Cleveland Clinic). He treats benign urologic conditions such as prostate enlargement(BPH) stone disease, and erectile dysfunction. He also specializes in the treatment of urologic cancers (renal cancer, prostate cancer, penile cancer, bladder cancer, and testicular cancer). His surgical experience includes robotic and minimally invasive surgery, endourology, general urology, and urologic oncology. In addition to general urology procedures, he also performs advanced urologic surgeries including open and robotic retroperitoneal lymph node dissection for metastatic testicular cancer; radical nephrectomy with caval thrombectomy for advanced stage kidney cancer, and radical cystectomy for bladder cancer.
Medical School:

University of Wisconsin - Madison

Residency:

University of Rochester

Fellowship:

Urologic Oncology, Cleveland Clinic

Undergraduate:

Stanford University

Locations

Center for Urology Rochester, New York

2615 Culver Road Suite 100Rochester, New York, 14609United States
585-336-5320 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only